HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients

BACKGROUND: HIV-associated general immune activation is a strong predictor for HIV disease progression, suggesting that chronic immune activation may drive HIV pathogenesis. Consequently, immunomodulating agents may decelerate HIV disease progression. METHODS: In an observational study, we determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasang, Christa, Ulmer, Albrecht, Donhauser, Norbert, Schmidt, Barbara, Stich, August, Klinker, Hartwig, Kalluvya, Samuel, Koutsilieri, Eleni, Rethwilm, Axel, Scheller, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282641/
https://www.ncbi.nlm.nih.gov/pubmed/22264238
http://dx.doi.org/10.1186/1471-2334-12-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282641/
https://www.ncbi.nlm.nih.gov/pubmed/22264238
http://dx.doi.org/10.1186/1471-2334-12-14

Ejemplares similares